Phase 3 Trial

NE3107 Drug Therapy

BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024

Staff Reporter March 2, 2024 0

BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological...

Read More

Interesting Stories For You

KW Delhi-6 Mall Joined Hands with Yashoda Healthcare to Spread Awareness on Breast Cancer

Staff Reporter November 7, 2024 0

India’s reputation as the “Pharmacy to the World” is Potentially Under Threat Substandard Imports of IPA add to the Quality Burden

Staff Reporter September 25, 2024 0
Dr. Vivek Kumar, Senior Consulting Cosmetic & Plastic Surgeon at Sculpt Clinics, Delhi, India, smiling.

Sculpt Clinics Introduces New Laser Hair Removal Technology

Staff Reporter September 6, 2024 0

HEAL Foundation Announces Healthcare CSR Summit & Awards in New Delhi

Staff Reporter August 22, 2024 0
Apsara Ice Creams Muskaan Initiative 53rd Anniversary Celebration

Apsara Ice Creams to launch Muskaan initiative on its 53rd anniversary

Staff Reporter August 16, 2024 0